Search Within

Maria Eugenia Arcila

Formats
  1. Meeting Abstract (391)
  2. Journal Article (247)
  3. Research Letter (12)
  4. Book Section (8)
  5. Review (7)
  6. Editorial (2)
  7. Guidelines (2)
  8. Book Whole (1)
Groups
  1. Department of Pathology and Laboratory Medicine (670)
  2. Department of Medicine (458)
  3. GSK Faculty (456)
  4. Human Oncology and Pathogenesis Program (427)
  5. Tow Center for Developmental Oncology (TCDO) (346)
  6. Solid Tumor Oncology Division (317)

More Groups

People
  1. Marc Ladanyi (301)
  2. Michael Berger (163)
  3. Ahmet Zehir (126)
  4. Mark Kris (123)
  5. Khedoudja Nafa (108)
  6. Ryma Benayed (99)

More People

Years
  1. 2025 (11)
  2. 2024 (29)
  3. 2023 (43)
  4. 2022 (32)
  5. 2021 (37)
  6. 2020 (68)

More Years

Publications
  1. Journal of Molecular Diagnostics (93)
  2. Journal of Clinical Oncology (80)
  3. Laboratory Investigation (74)
  4. Modern Pathology (69)
  5. Blood (55)
  6. Clinical Cancer Research (36)

More Publications

Publishers
  1. Elsevier Science, Inc. (98)
  2. Nature Publishing Group (97)
  3. American Society of Clinical Oncology (96)
  4. Nature Research (69)
  5. American Association for Cancer Research (61)
  6. American Society of Hematology (61)

More Publishers

Results (670)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Micropapillary pattern and invasive tumor size are prognostic factors in invasive mucinous adenocarcinoma of the lung
    Meeting Abstract

    Kadota, K.; Rekhtman, N.; Moreira, A. L.; Arcila, M. E.; Rusch, V. W.; Adusumilli, P. S.; Travis, W. D.
    Laboratory Investigation (2014)

    Fulltext@MSK | Save
  • Micropapillary pattern and invasive tumor size are prognostic factors in invasive mucinous adenocarcinoma of the lung
    Meeting Abstract

    Kadota, K.; Rekhtman, N.; Moreira, A. L.; Arcila, M. E.; Rusch, V. W.; Adusumilli, P. S.; Travis, W. D.
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • Poor prognostic driver mutations in early stage lung adenocarcinomas (LADs): BRAF and KRAS mutations for all LADs and KRAS mutations within the solid subtype alone
    Meeting Abstract

    Kadota, K.; Arcila, M. E.; Hedvat, C.; Kris, M. G.; Rusch, V. W.; Adusumilli, P. S.; Travis, W. D.
    Laboratory Investigation (2014)

    Fulltext@MSK | Save
  • Spectrum of primary and secondary mutations in gastrointestinal stromal tumors: Molecular analysis of 244 cases
    Meeting Abstract

    Hechtman, J. F.; Hameed, M.; Oultache, A.; Kuk, D.; Chi, P.; Dogan, S.; Arcila, M. E.; Ladanyi, M.; Nafa, K.
    Laboratory Investigation (2014)

    Fulltext@MSK | Save
  • Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
    Journal Article

    Davila, M. L.; Riviere, I.; Wang, X.; Bartido, S.; Park, J.; Curran, K.; Chung, S. S.; Stefanski, J.; Borquez-Ojeda, O.; Olszewska, M.; more...
    Science Translational Medicine (2014)

    Fulltext@MSK | Save
  • Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testing
    Journal Article

    Yu, H. A.; Arcila, M. E.; Hellmann, M. D.; Kris, M. G.; Ladanyi, M.; Riely, G. J.
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Unsuspected collision of synchronous lung adenocarcinomas: A potential cause of aberrant driver mutation profiles
    Journal Article

    Rekhtman, N.; Borsu, L.; Reva, B.; Arcila, M.; Riely, G. J.; Ladanyi, M.; Drilon, A.
    Journal of Thoracic Oncology (2014)

    Fulltext@MSK | Save
  • Response to erlotinib and prognosis for patients with de novo epidermal growth factor receptor (EGFR) T790M mutations
    Meeting Abstract

    Riely, G. J.; Yu, H. A.; Arcila, M. E.; Hellmann, M. D.; Ladanyi, M.; Kris, M. G.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A retrospective analysis of the prevalence of EGFR or KRAS mutations in patients (pts) with crizotinib-naive and crizotinib-resistant, ALK-positive non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Gainor, J. F.; Varghese, A. M.; Ou, S. H. I.; Kabraji, S.; Awad, M. M.; Katayama, R.; Pawlak, A.; Mino-Kenudson, M.; Yeap, B. Y.; Riely, G. J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Extensive high-depth sequencing of longitudinal CLL samples identifies frequent mutations in MAP kinase signaling and novel mutations activating notch and beta-catenin
    Meeting Abstract

    Gardner, J. R.; Nahas, M. K.; He, J.; Patel, M.; Knapp, K. M.; Palomba, M. L.; Yelensky, R.; Donahue, A. L.; Otto, G. A.; Arcila, M.; more...
    Blood (2013)

    Fulltext@MSK | Save